1. Home
  2. GEOS vs RNTX Comparison

GEOS vs RNTX Comparison

Compare GEOS & RNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Geospace Technologies Corporation (Texas)

GEOS

Geospace Technologies Corporation (Texas)

N/A

Current Price

$3.79

Market Cap

61.4M

Sector

Industrials

ML Signal

N/A

Logo Rein Therapeutics Inc.

RNTX

Rein Therapeutics Inc.

N/A

Current Price

$0.60

Market Cap

57.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GEOS
RNTX
Founded
1980
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
61.4M
57.8M
IPO Year
1997
2017

Fundamental Metrics

Financial Performance
Metric
GEOS
RNTX
Price
$3.79
$0.60
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $6.00
AVG Volume (30 Days)
83.9K
★ 400.4K
Earning Date
11-19-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 44.16
EPS
N/A
★ N/A
Revenue
★ $110,803,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$3.92
$0.54
52 Week High
$28.77
$2.10

Technical Indicators

Market Signals
Indicator
GEOS
RNTX
Relative Strength Index (RSI) 31.95 41.56
Support Level N/A $0.54
Resistance Level $4.80 $0.87
Average True Range (ATR) 0.24 0.07
MACD -0.05 0.00
Stochastic Oscillator 19.95 29.67

Price Performance

Historical Comparison
GEOS
RNTX

About GEOS Geospace Technologies Corporation (Texas)

Geospace Technologies Corp is engaged in designing and manufacturing sophisticated technology solutions for applications in smart water management, energy exploration, as well as industrial and Internet of Things. Its seismic equipment is used to locate, characterize, and monitor hydrocarbon reservoirs and is also marketed for vibration monitoring, security, and geotechnical uses. The company also produces non-seismic products such as Hydroconn cables, imaging equipment, remote shutoff water valves, and IoT platforms, and provides contract manufacturing services. The company's business segments includes Smart Water, Energy Solutions and Intelligent Industrial. The majority of its revenue is generated from the Energy Solutions segment.

About RNTX Rein Therapeutics Inc.

Rein Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing novel therapies for the treatment of orphan pulmonary and fibrosis indications with no approved or limited effective treatments. Its pipeline includes: LTI-03, a peptide, for placebo-controlled safety, tolerability, and pharmacodynamic biomarker activity trial in development for the treatment of Idiopathic Pulmonary Fibrosis, that has demonstrated the ability to protect healthy lung epithelial cells and reduce pro-fibrotic signaling; LTI-01, a proenzyme that completed a Phase 2a dose-ranging, placebo-controlled trial and a Phase 1b safety, tolerability and proof of mechanism trial in loculated pleural effusion, or LPE, patients, an indication that has no approved drug treatment.

Share on Social Networks: